Biotech Breakouts | August 27th FDA Insider Watch List

Lots of action last Thursday to book profits in a few names into strength. That is something I’ve learned to do when markets have been choppy with low volume.

I’ll have those same names on watch this week to start averaging back into to any dips.

As we stomp our way closer to Labor Day, things are going to start to pick up even more.

I’m getting ready to put some larger cap names on the watch list as well. Those include INCYTBPHEGRX, and CLVS – all of which will be updated tomorrow.

Reminder: Charts are updated every Sunday evening for the next week!


—– Related —–

FREE DOWNLOAD
Kyle Dennis FREE EBOOK “The $2.9 Million Biotech Trader Playbook”

This book has helped thousands of other traders learn the basics of biotech, and how to easily spot winning trades.

Whether you are new trader or a 30-year veteran, this book will help you find stocks that are primed to make parabolic moves. These strategies are Kyle’s secret weapons that have help him net over $3 Million in profits…and they are all yours for free.

This is normally $97.00, but it’s yours FREE!


Catalyst Swing Names (1-4 week holds) that I am watching

Checkpoint Therapeutics (CKPT)

Catalyst Dates: Phase 1/2 late breaking data due out September 24th

Buy Zone: $3.55 to $3.95

Profit Zone: $4.50 or higher

Stop Zone: $3.30 or below

 

BioLineRX (BLRX)

Catalyst Dates: Phase 2 topline results due out October 19th

Buy Zone: $.87 to $.92

Profit Zone: $1.00 or higher

Stop Zone: $.85 or below

 

Soligenix (SNGX)

Catalyst Dates: Phase 3 interim analysis due out in October 2018.

Buy Zone: $1.35 to $1.55

Profit Zone: $1.80 or higher

Stop Zone: $1.15 or below

 

Mirati Therapeutics (MRTX)

Catalyst Dates: Phase 1 and Phase 2 data due out October 21 and 22.

Buy Zone: $55.00 to $58.00

Profit Zone: $65.00 or higher

Stop Zone: $50.50 or below

 

Adma Biologics (ADMA)

Catalyst Dates: FDA Approval date of October 25th 2018.

Buy Zone: $5.50 to $5.80

Profit Zone: $6.25 or higher

Stop Zone: $5.30 or below

 

AcelRx (ACRX)

Catalyst Dates: FDA Approval date of November 3, likely to have an 
Advisory Committee meeting announce beforehand.

Buy Zone: $2.60 to $2.90

Profit Zone: $3.40 or higher

Stop Zone: $2.50 or below

 

Verastem (VSTM)

Catalyst Dates: FDA approval date of October 5th. Earnings should be August 8th.

Buy Zone: $8.50 to $8.85

Profit Zone: $9.50 or higher

Stop Zone: $8.00 or below

 

Viking Therapeutics (VKTX)

Catalyst Dates: Phase 2 data due September 30th. Another Phase 2 data set due out likely in late 2018.

Buy Zone: $9.75 to $10.35

Profit Zone: $12.00 or higher

Stop Zone: $9.40 or below

 

Selecta Biosciences (SELB)

Catalyst Dates:  Phase 2 data due out in October

Buy Zone: $12.00 to $13.00

Profit Zone: $16.00 or higher

Stop Zone: $11.50 or below

 

Trevena (TRVN)

Catalyst Dates: FDA Approval date of November 2, likely to have an 
Advisory Committee meeting announce beforehand

Buy Zone: $1.40 to $1.60

Profit Zone: $2.10 or higher

Stop Zone: $1.30 or below


[Ed.note: Kyle Dennis runs BiotechBreakouts.com. He is an event-based trader, who prefers low-priced and small-cap biotech stocks.

To learn more JOIN THIS SPECIAL ONLINE EVENT: 3-Step Plan Kyle Used to Turn $15,253 into $2,855,475 and download his FREE “The $2.9 Million Biotech Trader Playbook here!]

Leave a Comment